Glenmark Pharmaceuticals Hits All-Time High, Outperforms Sector with Strong Performance
Glenmark Pharmaceuticals Ltd., a top player in the pharmaceuticals and drugs industry, achieved an all-time high price on October 13, 2024. The stock outperformed the sector by 1.12% and is currently trading above its moving averages. In the past year, the company has shown a remarkable 130.00% increase, highlighting its strong market position and potential for consistent growth. MarketsMojo has given a 'Hold' call for the stock, allowing investors to track its performance and make informed decisions.
Glenmark Pharmaceuticals Ltd., a largecap company in the pharmaceuticals and drugs industry, has reached an all-time high price on October 13, 2024. The stock has been given a 'Hold' call by MarketsMOJO, a leading financial analysis platform.
On this day, the stock hit a new 52-week high of Rs. 1805, outperforming the sector by 1.12%. It also touched an intraday high of Rs. 1805, showing a 2.82% increase. Glenmark Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In the past year, Glenmark Pharmaceuticals has shown a remarkable performance with a 130.00% increase, while the Sensex has only grown by 22.43%. This highlights the company's strong position in the market and its ability to deliver consistent growth.
Glenmark Pharmaceuticals is a leading player in the pharmaceuticals and drugs industry, with a large market cap. The company's recent all-time high price is a testament to its strong performance and potential for future growth. With a 'Hold' call from MarketsMOJO, investors can continue to monitor the stock's performance and make informed decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Activity
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Most Read
